This content is machine translated Guselkumab Now also available as a patient-friendly ready-to-use pen The device, which was recently approved by Swissmedic, enables psoriasis sufferers to self-administer the biologic in single doses. It is currently the only IL23 inhibitor available in Switzerland in the…
